Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 34 | 2020 | 301 | 5.600 |
Why?
|
| Obesity | 27 | 2015 | 575 | 3.840 |
Why?
|
| Weight Loss | 23 | 2015 | 119 | 3.290 |
Why?
|
| Life Style | 16 | 2015 | 113 | 2.640 |
Why?
|
| Overweight | 15 | 2015 | 106 | 2.250 |
Why?
|
| Weight Reduction Programs | 8 | 2015 | 21 | 2.160 |
Why?
|
| Motor Activity | 8 | 2015 | 125 | 1.320 |
Why?
|
| Middle Aged | 44 | 2019 | 4230 | 1.290 |
Why?
|
| Aged | 33 | 2018 | 2807 | 1.080 |
Why?
|
| Behavior Therapy | 7 | 2015 | 53 | 0.980 |
Why?
|
| Body Mass Index | 17 | 2015 | 391 | 0.900 |
Why?
|
| Female | 49 | 2019 | 15228 | 0.860 |
Why?
|
| Diabetes Mellitus | 4 | 2019 | 166 | 0.850 |
Why?
|
| Energy Intake | 7 | 2015 | 158 | 0.830 |
Why?
|
| Male | 40 | 2019 | 13636 | 0.800 |
Why?
|
| Humans | 55 | 2020 | 26278 | 0.770 |
Why?
|
| Telemedicine | 2 | 2020 | 61 | 0.760 |
Why?
|
| Diet, Reducing | 5 | 2015 | 18 | 0.750 |
Why?
|
| Cardiovascular Diseases | 9 | 2014 | 216 | 0.730 |
Why?
|
| Risk Reduction Behavior | 4 | 2015 | 37 | 0.720 |
Why?
|
| Estrogens, Conjugated (USP) | 5 | 2011 | 8 | 0.710 |
Why?
|
| Community Health Workers | 2 | 2019 | 27 | 0.690 |
Why?
|
| Exercise | 5 | 2012 | 286 | 0.670 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 26 | 0.660 |
Why?
|
| Patient Education as Topic | 10 | 2015 | 83 | 0.630 |
Why?
|
| Postmenopause | 7 | 2011 | 38 | 0.610 |
Why?
|
| Medically Underserved Area | 1 | 2019 | 8 | 0.600 |
Why?
|
| House Calls | 1 | 2019 | 6 | 0.600 |
Why?
|
| Body Weight | 4 | 2015 | 305 | 0.600 |
Why?
|
| Depression | 3 | 2015 | 139 | 0.580 |
Why?
|
| Diet | 3 | 2012 | 393 | 0.570 |
Why?
|
| Psychotherapy, Group | 1 | 2017 | 14 | 0.550 |
Why?
|
| Metformin | 1 | 2017 | 38 | 0.540 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 96 | 0.520 |
Why?
|
| Patient Care Team | 1 | 2017 | 127 | 0.510 |
Why?
|
| Treatment Outcome | 12 | 2017 | 2183 | 0.500 |
Why?
|
| Mexican Americans | 5 | 2015 | 36 | 0.490 |
Why?
|
| School Health Services | 1 | 2015 | 45 | 0.470 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2010 | 4 | 0.470 |
Why?
|
| Diet, Fat-Restricted | 3 | 2015 | 14 | 0.450 |
Why?
|
| Self Report | 2 | 2015 | 120 | 0.440 |
Why?
|
| Vitamin D | 3 | 2018 | 29 | 0.430 |
Why?
|
| Adiponectin | 2 | 2015 | 39 | 0.420 |
Why?
|
| Dietary Supplements | 4 | 2018 | 88 | 0.420 |
Why?
|
| Physical Fitness | 3 | 2015 | 20 | 0.420 |
Why?
|
| Breast Neoplasms | 4 | 2011 | 1005 | 0.410 |
Why?
|
| Risk Factors | 13 | 2014 | 2065 | 0.410 |
Why?
|
| Energy Metabolism | 2 | 2015 | 252 | 0.400 |
Why?
|
| Adult | 10 | 2020 | 5769 | 0.390 |
Why?
|
| United States | 12 | 2015 | 1722 | 0.390 |
Why?
|
| Exercise Therapy | 4 | 2015 | 22 | 0.390 |
Why?
|
| Follow-Up Studies | 10 | 2015 | 1135 | 0.380 |
Why?
|
| Patient Selection | 4 | 2011 | 82 | 0.380 |
Why?
|
| Adipokines | 1 | 2012 | 26 | 0.380 |
Why?
|
| Adolescent Development | 1 | 2012 | 10 | 0.370 |
Why?
|
| Blood Glucose | 7 | 2019 | 276 | 0.370 |
Why?
|
| Cholecalciferol | 2 | 2018 | 4 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2015 | 133 | 0.370 |
Why?
|
| Prediabetic State | 2 | 2018 | 16 | 0.360 |
Why?
|
| Genetic Loci | 2 | 2012 | 81 | 0.360 |
Why?
|
| Child Development | 1 | 2012 | 76 | 0.360 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 165 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2011 | 4 | 0.340 |
Why?
|
| Research Design | 3 | 2014 | 137 | 0.330 |
Why?
|
| Pain | 1 | 2010 | 45 | 0.330 |
Why?
|
| Health Behavior | 3 | 2014 | 144 | 0.320 |
Why?
|
| Residence Characteristics | 2 | 2011 | 68 | 0.320 |
Why?
|
| Blood Pressure | 4 | 2014 | 213 | 0.320 |
Why?
|
| Feeding Behavior | 4 | 2012 | 320 | 0.320 |
Why?
|
| Cholesterol, HDL | 3 | 2014 | 42 | 0.290 |
Why?
|
| Incidence | 9 | 2018 | 631 | 0.290 |
Why?
|
| Poverty | 2 | 2019 | 95 | 0.270 |
Why?
|
| Health Education | 2 | 2014 | 79 | 0.270 |
Why?
|
| Diabetes Complications | 2 | 2012 | 34 | 0.260 |
Why?
|
| Bone Density | 2 | 2012 | 70 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 709 | 0.240 |
Why?
|
| Hypertension | 2 | 2015 | 215 | 0.230 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 17 | 0.230 |
Why?
|
| Foods, Specialized | 1 | 2015 | 1 | 0.230 |
Why?
|
| Diet Therapy | 1 | 2015 | 9 | 0.230 |
Why?
|
| Diet, Diabetic | 1 | 2015 | 4 | 0.230 |
Why?
|
| Regression Analysis | 3 | 2017 | 156 | 0.230 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 50 | 0.220 |
Why?
|
| Body Composition | 1 | 2015 | 152 | 0.220 |
Why?
|
| Double-Blind Method | 6 | 2018 | 268 | 0.220 |
Why?
|
| Ankle Brachial Index | 1 | 2014 | 5 | 0.220 |
Why?
|
| Alleles | 2 | 2012 | 367 | 0.210 |
Why?
|
| Nutrition Policy | 2 | 2015 | 39 | 0.210 |
Why?
|
| Schools | 2 | 2015 | 91 | 0.200 |
Why?
|
| Group Processes | 2 | 2019 | 10 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 2 | 2010 | 5 | 0.190 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 259 | 0.190 |
Why?
|
| Mammography | 2 | 2009 | 14 | 0.190 |
Why?
|
| Quality of Life | 2 | 2019 | 312 | 0.190 |
Why?
|
| Heart Rate | 1 | 2012 | 148 | 0.180 |
Why?
|
| Women's Health | 2 | 2008 | 26 | 0.180 |
Why?
|
| Biomarkers | 4 | 2014 | 566 | 0.180 |
Why?
|
| Time Factors | 4 | 2014 | 1222 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 230 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 275 | 0.180 |
Why?
|
| Hysterectomy | 1 | 2011 | 20 | 0.180 |
Why?
|
| Social Class | 1 | 2011 | 47 | 0.170 |
Why?
|
| Coronary Disease | 1 | 2011 | 45 | 0.170 |
Why?
|
| Proportional Hazards Models | 4 | 2014 | 310 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2011 | 40 | 0.170 |
Why?
|
| Restaurants | 1 | 2010 | 4 | 0.170 |
Why?
|
| Child | 7 | 2015 | 8226 | 0.170 |
Why?
|
| Estrogens | 1 | 2011 | 146 | 0.160 |
Why?
|
| Adolescent | 4 | 2015 | 5813 | 0.160 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 36 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 105 | 0.150 |
Why?
|
| Dietary Fats | 1 | 2009 | 69 | 0.150 |
Why?
|
| Vegetables | 2 | 2011 | 131 | 0.150 |
Why?
|
| Calcium Compounds | 1 | 2008 | 1 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2017 | 195 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2008 | 24 | 0.150 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 5 | 0.150 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 10 | 0.150 |
Why?
|
| Cholesterol, LDL | 3 | 2014 | 46 | 0.150 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 44 | 0.140 |
Why?
|
| Triglycerides | 3 | 2014 | 96 | 0.140 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 220 | 0.130 |
Why?
|
| Risk | 3 | 2012 | 173 | 0.130 |
Why?
|
| Aging | 1 | 2008 | 223 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2018 | 1127 | 0.130 |
Why?
|
| Acculturation | 1 | 2015 | 22 | 0.120 |
Why?
|
| Fractures, Bone | 2 | 2009 | 32 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 814 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 39 | 0.100 |
Why?
|
| Absorptiometry, Photon | 2 | 2015 | 45 | 0.100 |
Why?
|
| Peptide Hormones | 1 | 2013 | 26 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2011 | 151 | 0.100 |
Why?
|
| Texas | 2 | 2019 | 1145 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 91 | 0.100 |
Why?
|
| Logistic Models | 1 | 2014 | 318 | 0.100 |
Why?
|
| Parents | 1 | 2015 | 363 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 219 | 0.090 |
Why?
|
| Nutritional Sciences | 1 | 2012 | 16 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 360 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 824 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2012 | 219 | 0.090 |
Why?
|
| Taste | 1 | 2011 | 8 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 24 | 0.090 |
Why?
|
| Psychology, Child | 1 | 2011 | 10 | 0.090 |
Why?
|
| Neoplasms | 1 | 2008 | 720 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2014 | 259 | 0.090 |
Why?
|
| Food Preferences | 1 | 2011 | 54 | 0.090 |
Why?
|
| Knee | 1 | 2010 | 6 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2010 | 46 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 117 | 0.080 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2009 | 4 | 0.080 |
Why?
|
| Edible Grain | 1 | 2009 | 14 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 579 | 0.080 |
Why?
|
| Linear Models | 2 | 2009 | 129 | 0.070 |
Why?
|
| Placebos | 2 | 2014 | 52 | 0.070 |
Why?
|
| Fruit | 1 | 2009 | 87 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2017 | 4036 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 318 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2015 | 157 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 901 | 0.070 |
Why?
|
| Hip Fractures | 2 | 2011 | 3 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 477 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2008 | 515 | 0.060 |
Why?
|
| Caloric Restriction | 1 | 2015 | 13 | 0.060 |
Why?
|
| Snacks | 1 | 2015 | 12 | 0.060 |
Why?
|
| Data Accuracy | 1 | 2014 | 3 | 0.060 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 14 | 0.060 |
Why?
|
| Policy Making | 1 | 2014 | 16 | 0.060 |
Why?
|
| Exercise Test | 1 | 2015 | 67 | 0.060 |
Why?
|
| Sex Factors | 2 | 2009 | 228 | 0.060 |
Why?
|
| Health Policy | 1 | 2014 | 34 | 0.060 |
Why?
|
| Meals | 1 | 2015 | 35 | 0.060 |
Why?
|
| Self Care | 1 | 2015 | 57 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2014 | 47 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2015 | 67 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 12 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 56 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2014 | 33 | 0.050 |
Why?
|
| Comorbidity | 1 | 2014 | 220 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 301 | 0.050 |
Why?
|
| Mobility Limitation | 1 | 2012 | 5 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2012 | 14 | 0.050 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2012 | 1 | 0.050 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2012 | 1 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 3 | 0.050 |
Why?
|
| Dairy Products | 1 | 2012 | 25 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2012 | 41 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 21 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 228 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2012 | 22 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 16 | 0.050 |
Why?
|
| Dietary Proteins | 1 | 2012 | 68 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2011 | 9 | 0.040 |
Why?
|
| Urban Population | 1 | 2011 | 41 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 43 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 102 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 208 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 131 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 574 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 219 | 0.040 |
Why?
|
| Stroke | 1 | 2011 | 119 | 0.040 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 9 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 242 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2019 | 2 | 0.040 |
Why?
|
| Causality | 1 | 2009 | 16 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 159 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 636 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 289 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 523 | 0.030 |
Why?
|
| Prognosis | 1 | 2010 | 1190 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2008 | 778 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 874 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 37 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2015 | 20 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 173 | 0.030 |
Why?
|
| Young Adult | 1 | 2010 | 2355 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 180 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 406 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 82 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2013 | 116 | 0.030 |
Why?
|
| Lipids | 1 | 2013 | 87 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 186 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 169 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 338 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 60 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 92 | 0.020 |
Why?
|
| Arachis | 1 | 2011 | 23 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 115 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 87 | 0.020 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2011 | 46 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 39 | 0.020 |
Why?
|
| Spinal Fractures | 1 | 2009 | 6 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2009 | 10 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 328 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 617 | 0.020 |
Why?
|